Severe maternal morbidity: screening and review




This document builds upon recommendations from peer organizations and outlines a process for identifying maternal cases that should be reviewed. Severe maternal morbidity is associated with a high rate of preventability, similar to that of maternal mortality. It also can be considered a near miss for maternal mortality because without identification and treatment, in some cases, these conditions would lead to maternal death. Identifying severe morbidity is, therefore, important for preventing such injuries that lead to mortality and for highlighting opportunities to avoid repeat injuries. The two-step screen and review process described in this document is intended to efficiently detect severe maternal morbidity in women and to ensure that each case undergoes a review to determine whether there were opportunities for improvement in care. Like cases of maternal mortality, cases of severe maternal morbidity merit quality review. In the absence of consensus on a comprehensive list of conditions that represent severe maternal morbidity, institutions and systems should either adopt an existing screening criteria or create their own list of outcomes that merit review.





The information reflects emerging clinical and scientific advances as of the date issued, is subject to change, and should not be construed as dictating an exclusive course of treatment or procedure. Variations in practice may be warranted based on the needs of the individual patient, resources, and limitations unique to the institution or type of practice.



Introduction


This document builds upon recommendations from peer organizations and outlines a process for identifying maternal cases that should be reviewed. Different groups have offered different definitions of severe morbidity and proposed lists of conditions and complications that constitute severe morbidity. These definitions share the concept that severe maternal morbidity can be thought of as unintended outcomes of the process of labor and delivery that result in significant short-term or long-term consequences to a woman’s health. The American College of Obstetricians and Gynecologists (the College) and the Society for Maternal–Fetal Medicine (SMFM) have not yet created or endorsed a single, comprehensive definition of severe maternal morbidity. Creating a consensus definition of severe maternal morbidity is beyond the scope of this document and may be the focus of future work. In the interval, however, using this recommended process to identify potential cases of severe maternal morbidity for further review, with a focus on outcomes and complications, is an important step toward promoting safe obstetric care. Like cases of maternal mortality, cases of severe maternal morbidity merit quality review. The purpose of identifying and evaluating these cases is to facilitate opportunities for improvement in care. However, neither intensive care unit (ICU) admission or transfusion of 4 or more units of blood should be used as quality metrics because some cases of morbidity reflect the underlying health of a woman or her pregnancy and, thus, are unavoidable.




Background


Like maternal mortality, severe maternal morbidity is increasing in the United States. Severe maternal morbidity is associated with a high rate of preventability, similar to that of maternal mortality. It also can be considered a near miss for maternal mortality because without identification and treatment, in some cases, these conditions would lead to maternal death. Identifying severe morbidity is, therefore, important for preventing such injuries that lead to mortality and for highlighting opportunities to avoid repeat injuries. Responding to these concepts, multidisciplinary expert groups have called for all obstetric hospitals to review their cases of severe maternal morbidity to look for opportunities for improvement in care that could lead to improved maternal outcomes and fewer maternal deaths. These calls are supported by the College; SMFM; the Association of Women’s Health, Obstetric and Neonatal Nurses; the American College of Nurse–Midwives; and other groups.




Background


Like maternal mortality, severe maternal morbidity is increasing in the United States. Severe maternal morbidity is associated with a high rate of preventability, similar to that of maternal mortality. It also can be considered a near miss for maternal mortality because without identification and treatment, in some cases, these conditions would lead to maternal death. Identifying severe morbidity is, therefore, important for preventing such injuries that lead to mortality and for highlighting opportunities to avoid repeat injuries. Responding to these concepts, multidisciplinary expert groups have called for all obstetric hospitals to review their cases of severe maternal morbidity to look for opportunities for improvement in care that could lead to improved maternal outcomes and fewer maternal deaths. These calls are supported by the College; SMFM; the Association of Women’s Health, Obstetric and Neonatal Nurses; the American College of Nurse–Midwives; and other groups.




Clinical considerations and management


What is severe maternal morbidity?


Severe maternal morbidity can be thought of as unintended outcomes of the process of labor and delivery that result in significant short-term or long-term consequences to a woman’s health. To date, there is not complete consensus among systems and professional organizations as to what conditions should represent severe maternal morbidity. Developing such a list in the future has clear utility. In the absence of consensus on a comprehensive list of conditions that represent severe maternal morbidity, institutions and systems should either adopt an existing screening criteria or create their own list of outcomes that merit review. Such lists may be based on the institutions’ evaluations of which adverse outcomes are consequential to their population. Table 1 presents an example of a list of conditions that represent severe maternal morbidity. In some cases, however, an identified morbidity actually may not prove to be severe morbidity after chart review. For example, if a parturient with complex congenital heart disease has a planned ICU admission to receive safe intrapartum care and does not ultimately require any significant intervention aside from observation, she would not be categorized as a patient with a severe morbidity. In contrast, a woman who develops acute heart failure requiring ICU admission and significant interventions to manage her heart failure would be considered a patient with a severe maternal morbidity. Identifying an outcome as a severe maternal morbidity does not suggest blame, nor does it mean that there will always be an opportunity for improvement. Reviewing such cases in detail to determine whether the morbidity may have been avoidable and whether it should prompt changes in systems for care provision is, however, a necessary and important step in efforts to ensure quality obstetric care. For example, although amniotic fluid embolisms are “unpredictable and unavoidable,” reviewing all such cases to evaluate responses to these unexpected life-threatening emergencies potentially can improve future responses.



Table 1

Example list of diagnoses and complications constituting severe maternal morbidity














































































































































Severe Maternal Morbidity Not Severe Morbidity (insufficient evidence if this is the only criteria)
Hemorrhage
Obstetric hemorrhage with ≥4 units of red blood cells transfused Obstetric hemorrhage with 2–3 units of red blood cells transfused ALONE
Obstetric hemorrhage with 2 units of red blood cells and 2 units of fresh frozen plasma transfused (without other procedures or complications) if not judged to be overexuberant transfusion Obstetric hemorrhage with 2 units of red blood cells and 2 units of fresh frozen plasma transfused AND judged to be “overexuberant”
Obstetric hemorrhage with <4 units of blood products transfused and evidence of pulmonary congestion that requires >1 dose of furosemide Obstetric hemorrhage with <4 units of blood products transfused and evidence of pulmonary edema requiring only 1 dose of furosemide
Obstetric hemorrhage with return to operating room for any major procedure (excludes dilation)
Any emergency/unplanned peripartum hysterectomy, regardless of number of units transfused (includes all placenta accretas) Planned peripartum hysterectomy for cancer/neoplasia
Obstetric hemorrhage with uterine artery embolization, regardless of number of units transfused
Obstetric hemorrhage with uterine balloon or uterine compression suture placed and 2–3 units of blood products transfused Obstetric hemorrhage with uterine balloon or uterine compression suture placed and ≤1 unit of blood products transfused
Obstetric hemorrhage admitted to intensive care unit for invasive monitoring or treatment (either medication or procedure; not just observed overnight) Any obstetric hemorrhage that went to the intensive care unit for observation only without further treatment
Hypertension/Neurologic
Eclamptic seizure(s) or epileptic seizures that were “status”
Continuous infusion (intravenous drip) of an antihypertensive medication
Nonresponsiveness or loss of vision, permanent or temporary (but not momentary), documented in physician’s progress notes
Stroke, coma, intracranial hemorrhage
Preeclampsia with difficult-to-control severe hypertension (>160 systolic blood pressure or >110 diastolic blood pressure) that requires multiple intravenous doses, persistent ≥48 hours after delivery, or both Chronic hypertension that drifts up to severe range and needs postoperative medication dose alteration: preeclampsia blood pressure control with oral medications ≥48 hours after delivery
Liver or subcapsular hematoma or severe liver injury admitted to the intensive care unit (bilirubin >6 or liver enzymes >600) Abnormal liver function requiring extra prolonged postpartum length of stay but not in the intensive care unit
Multiple coagulation abnormalities or severe hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome Severe thrombocytopenia (<50,000) alone that does not require a transfusion or intensive care unit admission
Renal
Diagnosis of acute tubular necrosis or treatment with renal dialysis Oliguria treated with intravenous fluids (no intensive care unit admission)
Oliguria treated with multiple doses of Lasix Oliguria treated with 1 dose of intravenous fluids (no intensive care unit admission)
Creatinine ≥2.0 in a woman without preexisting renal disease OR a doubling of the baseline creatinine in a woman with preexisting renal disease
Sepsis
Infection with hypotension with multiple liters of intravenous fluid or pressors used (septic shock) Fever >38.5°C with elevated lactate alone without hypotension
Infection with pulmonary complications such as pulmonary edema or acute respiratory distress syndrome Fever >38.5°C with presumed choriometritis/endometritis with elevated pulse but no other cardiovascular signs and normal lactate
Positive blood culture without other evidence of significant systemic illness
Pulmonary
Diagnosis of acute respiratory distress syndrome, pulmonary edema, or postoperative pneumonia Administration of oxygen without a pulmonary diagnosis
Use of a ventilator (with either intubation or noninvasive technique)
Deep vein thrombosis or pulmonary embolism
Cardiac
Preexisting cardiac disease (congenital or acquired) with intensive care unit admission for treatment Preexisting cardiac disease (congenital or acquired) with intensive care unit admission for observation only
Peripartum cardiomyopathy Preexisting cardiac disease (congenital or acquired) without intensive care unit admission for observation only
Arrhythmia requiring >1 dose of intravenous medication but not intensive care unit admission Arrhythmia requiring 1 dose of intravenous medication but no intensive care unit admission
Arrhythmia that requires intensive care unit with further treatments Arrhythmia that requires intensive care unit observation but no extra treatments
Intensive Care Unit/Invasive Monitoring
Any intensive care unit admission that includes treatment or diagnostic or therapeutic procedure Intensive care unit admission for observation of hypertension that does NOT require intravenous medications
Central line or pulmonary catheter used to monitor a complication Intensive care unit admission for observation after general anesthesia
Surgical, Bladder, and Bowel Complications
Bowel or bladder injury during surgery beyond minor serosal tear
Small-bowel obstruction, with or without surgery during pregnancy/postpartum period
Prolonged ileus for ≥4 days Postoperative ileus that resolved without surgery in ≤3 days
Anesthesia Complications
Total spinal anesthesia Failed spinal anesthesia that requires general anesthesia
Aspiration pneumonia Spinal headache treated with a blood patch
Epidural hematoma

HELLP , hemolysis, elevated liver enzymes, and low platelet count.

Reprinted from Main EK, Abreo A, McNulty J, Gilbert W, McNally C, Poeltler D, et al. Measuring severe maternal morbidity: validation of potential measures. Am J Obstet Gynecol 2016;214:643.e1-10.

ACOG. Severe maternal morbidity: screening and review. Am J Obstet Gynecol 2016 .

This list provides a series of examples that may help facilities and health care providers as they evaluate cases to determine if they represent severe maternal morbidity. The College and SMFM have not created or endorsed a single, comprehensive definition of severe maternal morbidity.



What process can be used to identify cases with potential severe maternal morbidity that merit review?


Quality improvement efforts are predicated in part on identifying cases with potential severe maternal morbidity that merit review. Identifying such cases, however, is more complicated than reviewing maternal mortality, which is clearly defined and readily captured in death certificates and other reporting. Severe maternal morbidity, in contrast, is not always reported and may not be well coded in, or otherwise readily extracted from, record systems. Definitions of severe maternal morbidity that rely on diagnosis codes, such as the Centers for Disease Control and Prevention’s definition, may miss cases, have a relatively low positive predictive value (0.40) and, at a practical level, may be difficult for facilities to operationalize. Facilities should have a screening process in place to detect cases of severe maternal morbidity for review. The College and SMFM recommend using two criteria to screen for severe maternal morbidity: 1) transfusion of 4 or more units of blood and 2) admission of a pregnant or postpartum woman to an ICU. Investigators have demonstrated that these criteria have high sensitivity and specificity for identifying women with severe morbidity and a high positive predictive value (0.85) for identifying severe maternal morbidity.


Facilities should review all cases that meet at least one of these screening criteria to determine whether the case is truly a severe maternal morbidity; to characterize the events, diagnoses, and outcomes involved; and to determine if an identified morbidity is judged to have been potentially avoidable and, thus, present opportunities for system change and improved future performance. Not all cases that meet criteria for review will represent preventable severe morbidity; some cases of morbidity reflect the underlying health of a woman or her pregnancy and are thus unavoidable. The concept that not all cases meeting screening criteria will be true cases of severe maternal morbidity underscores the importance of reviewing each “screen-positive” case to identify those with true morbidity and, especially, those that may be deemed upon review to have been potentially avoidable.


When does severe maternal morbidity represent a sentinel event?


The Joint Commission defines a sentinel event as “a patient safety event (not primarily related to the natural course of the patient’s illness or underlying condition) that reaches a patient and results in any of the following: death, permanent harm, or temporary harm.” Simply screening positive for one of the two recommended screening criteria does not constitute a sentinel event. Instead, the Joint Commission noted that upon review of any case, the ultimate assessment may be that the case is not a sentinel event. For example, hemorrhage due to placenta previa would not qualify as a sentinel event because bleeding in this context is part of the natural course of the illness. As such, screen-positive cases or individual outcomes and diagnoses should not automatically be considered sentinel events. Context determined from detailed review is needed to determine if an individual case and outcome was correctly classified as a sentinel event. Just as the rate of ICU admission and transfusion of 4 or more units of blood should not automatically be labeled as sentinel events, their rates of occurrence should not be used as a quality metric. These screening criteria are the minimum recommended criteria and institutions may choose to incorporate additional screening criteria to highlight cases for detailed review at their own discretion.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

May 2, 2017 | Posted by in GYNECOLOGY | Comments Off on Severe maternal morbidity: screening and review

Full access? Get Clinical Tree

Get Clinical Tree app for offline access